Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Liabilities and Shareholders Equity Payables Prepaid Assets Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities

Growth Metrics

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing Operations Income towards Parent Company Net Income towards Common Stockholders Operating Expenses Operating Income Other Non Operating Income Other Operating Expenses Profit After Tax Selling, General & Administrative Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other

Others

EBIAT Long-Term Debt Issuances Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

Ratios

Bioforce Nanosciences Holdings (BFNH) Shares Outstanding (2019 - 2025)